LA JOLLA, CA – The U.S. Food and Drug Administration has approved tafamidis, a medicine invented by Scripps Research professors Jeffery Kelly, PhD, and Evan Powers, PhD, for the treatment of heart disease (cardiomyopathy) caused by mutant or wild-type transthyretin aggregation in adults.
↧